| Increased prevalence of epilepsy associated with severe falciparum malaria in children JA Carter, BGR Neville, S White, AJ Ross, G Otieno, N Mturi, C Musumba, ... Epilepsia 45 (8), 978-981, 2004 | 213 | 2004 |
| Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan … BR Ogutu, KO Onyango, N Koskei, EK Omondi, JM Ongecha, GA Otieno, ... Malaria journal 13, 1-10, 2014 | 74 | 2014 |
| Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria R Idro, G Otieno, S White, A Kahindi, G Fegan, B Ogutu, S Mithwani, ... Malaria Journal 4, 1-10, 2005 | 69 | 2005 |
| Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non … D Ishola, D Manno, MO Afolabi, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 97-109, 2022 | 67 | 2022 |
| Safety and immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial MO Afolabi, D Ishola, D Manno, B Keshinro, V Bockstal, B Rogers, ... The Lancet Infectious Diseases 22 (1), 110-122, 2022 | 59 | 2022 |
| Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa YG Mendoza, E Garric, A Leach, M Lievens, O Ofori-Anyinam, JY Pirçon, ... Human vaccines & immunotherapeutics, 2019 | 59 | 2019 |
| Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness J Makani, FJ Kirkham, A Komba, T Ajala‐Agbo, G Otieno, G Fegan, ... British journal of haematology 145 (4), 529-532, 2009 | 58 | 2009 |
| Intramuscular artesunate for severe malaria in African children: a multicenter randomized controlled trial PG Kremsner, AA Adegnika, AB Hounkpatin, JF Zinsou, TE Taylor, ... PLoS medicine 13 (1), e1001938, 2016 | 53 | 2016 |
| Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite … N Otsyula, E Angov, E Bergmann-Leitner, M Koech, F Khan, J Bennett, ... Malaria journal 12, 1-13, 2013 | 43 | 2013 |
| Safety and immunogenicity of the RTS, S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa L Otieno, YG Mendoza, S Adjei, T Agbenyega, ST Agnandji, P Aide, ... Vaccine 38 (4), 897-906, 2020 | 17 | 2020 |
| Safety and immunogenicity of an Ad26. ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an … D Manno, A Bangura, F Baiden, AB Kamara, P Ayieko, J Kallon, J Foster, ... The Lancet Infectious Diseases 23 (3), 352-360, 2023 | 13 | 2023 |
| Safety and immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled … EML Choi, B Lacarra, MO Afolabi, BM Ale, F Baiden, C Bétard, J Foster, ... The Lancet Global Health 11 (11), e1743-e1752, 2023 | 5 | 2023 |
| Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone D Manno, P Ayieko, D Ishola, MO Afolabi, B Rogers, F Baiden, ... Emerging Infectious Diseases 28 (3), 734, 2022 | 4 | 2022 |
| Antifungal effects of essential oils from mint and rosemary on peronospora destructor and Candida albicans BM Githaiga, EM Gathuru, PN Waithaka, GO Omondi Mediterranean Journal of Basic and Applied Sciences 2 (4), 05-12, 2018 | 1 | 2018 |
| PA-728 Exploring the disposition of select artemisinin combination therapies in the treatment of malaria and malaria parasite kinetics in children with sickle cell disease in Kenya GA Otieno, BR Ogutu BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa ET Agbenyega, YG Mendoza, L Schuerman, E Garric, A Leach, M Lievens, ... Taylor & Francis, 2019 | | 2019 |
| Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial ET Agbenyega, PG Kremsner, S Krishna, AA Adegnika, AB Hounkpatin, ... PLoS Medicine, 2015 | | 2015 |
| Acceptability and comparative efficacy of artemether-lumefantrine vs. dihydroartemisinin/piperaquine in Kenyan children with uncomplicated falciparum malaria KO Onyango, JM Ongecha, E Juma, GA Otieno, C Obonyo, L Otieno, ... TROPICAL MEDICINE & INTERNATIONAL HEALTH 16, 110-110, 2011 | | 2011 |
| Continuous EEG monitoring and seizures in children with cerebral malaria R Idro, S Gwer, G Otieno, E Chengo, M Boga, S Akech, K Maitland, ... NEUROLOGY 70 (11), A49-A49, 2008 | | 2008 |
| Clinical features and determinants of outcome of children admitted with malaria at Kenyatta National Hospital GA Otieno University of Nairobi, CHS, Kenya, 2008 | | 2008 |
